Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
colfoscerilpalmitat |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
Product containing tyloxapol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Colfosceril palmitate (substance) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tyloxapol (substance) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
Product containing cetyl alcohol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with alcohol structure (substance) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cetyl alcohol (substance) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lung surfactant (substance) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
Product containing tyloxapol in respiratory dosage form |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Has manufactured dose form |
inhalationsdoseringsform |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Has manufactured dose form |
Powder for inhalation |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
Product manufactured as pulmonary dose form (product) |
false |
Inferred relationship |
Some |
|
|
cetylalkohol 12 mg + colfoscerilpalmitat 108 mg + tyloxapol 8 mg pulver |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|